A sustained reduction in deaths from prostate cancer was observed with prostate-specific antigen (PSA) testing in long-term ...
Opposition parties at Queen’s Park are renewing calls for the government to cover a simple blood test that helps detect ...
MedPage Today on MSN
Mixed Results With Metformin for Men on ADT for Prostate Cancer
The favorable effects observed in the study "consolidate the finding that metformin not only improves anthropometric outcomes ...
Grape seed extract—a dietary supplement made from the seeds of wine grapes—has been investigated to see if it can help reduce ...
India Today on MSN
Why some men don't respond to prostate cancer therapy
The baffling question: why does prostate cancer relapse quickly in some patients while stabilising in others? Recent ...
News-Medical.Net on MSN
Breakthrough combo therapy lowers death risk in recurrent prostate cancer
Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...
In 2023, Kevin Shearman went to Townsville University Hospital for a biopsy. It took them two years to ring him back and ...
Enzalutamide plus leuprolide reduces the risk of death by more than 40% in biochemically recurrent prostate cancer compared to leuprolide alone.
Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...
RUMC hosted the screening and education program at the local JCC, bringing medical professionals together with the former All ...
MEN with suspected prostate cancer will be able to get a diagnosis on the NHS within a day, under “game-changing” new trials.
Prostate cancer screening for men over 70 is complex, with current recommendations against routine PSA testing due to slow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results